The Spice Sage and Its Active Ingredient Rosmarinic Acid Protect PC12 Cells from Amyloid-β Peptide-Induced Neurotoxicity
暂无分享,去创建一个
Angelo A. Izzo | Giuseppe Esposito | A. Izzo | G. Esposito | D. De Filippis | T. Iuvone | Teresa Iuvone | Daniele De Filippis | Alessandra D'Amico | A. D'Amico | A. D’Amico
[1] A. D. Cash,et al. Therapeutic potential in Alzheimer disease. , 2002, Current medicinal chemistry.
[2] R. Carnuccio,et al. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. , 2006, Journal of molecular medicine.
[3] L. Gao,et al. Antiapoptotic and antioxidant effects of rosmarinic acid in astrocytes. , 2005, Die Pharmazie.
[4] R E Burke,et al. Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.
[5] J. Ávila,et al. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. , 1999, FEBS letters.
[6] F. Galvano,et al. Effects of rosmarinic acid against aflatoxin B1 and ochratoxin‐A‐induced cell damage in a human hepatoma cell line (Hep G2) , 2004, Journal of applied toxicology : JAT.
[7] I. Fabian,et al. The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. , 2004, Biochemical pharmacology.
[8] Angelo A. Izzo,et al. The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells , 2006, Journal of Molecular Medicine.
[9] T. Gómez-Isla,et al. Expression of stress‐activated kinases c‐Jun N‐terminal kinase (SAPK/JNK‐P) and p38 kinase (p38‐P), and tau hyperphosphorylation in neurites surrounding βA plaques in APP Tg2576 mice , 2004, Neuropathology and applied neurobiology.
[10] N. Perry,et al. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders , 2003, Phytotherapy research : PTR.
[11] B. Zhivotovsky,et al. A comparative study of apoptosis and necrosis in HepG2 cells: oxidant-induced caspase inactivation leads to necrosis. , 1999, Biochemical and biophysical research communications.
[12] W. Ma,et al. Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures , 2002, Neuroscience.
[13] M. Simmonds,et al. Rosmarinic acid. , 2003, Phytochemistry.
[14] E. Perry,et al. EUROPEAN HERBS WITH CHOLINERGIC ACTIVITIES: POTENTIAL IN DEMENTIA THERAPY , 1996 .
[15] G. Wilcock,et al. Evidence-based pharmacotherapy of Alzheimer's disease. , 2004, The international journal of neuropsychopharmacology.
[16] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[17] Agneta Nordberg,et al. PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.
[18] T. Kubo,et al. In vivo conversion of racemized β‐amyloid ([D‐Ser26]Aβ1–40) to truncated and toxic fragments ([D‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients , 2002 .
[19] R. Bullock. Future directions in the treatment of Alzheimer’s disease , 2004, Expert opinion on investigational drugs.
[20] T. Yoshikawa,et al. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans , 2005, European journal of nutrition.
[21] Mohammad Reza Mohammadi,et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.
[22] Kenjiro Ono,et al. Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.
[23] Y. Yun,et al. Rosmarinic Acid Induces p56lck-Dependent Apoptosis in Jurkat and Peripheral T Cells via Mitochondrial Pathway Independent from Fas/Fas Ligand Interaction 1 , 2004, The Journal of Immunology.
[24] Andrea Caricasole,et al. The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease? , 2003, Trends in pharmacological sciences.
[25] Mohammad Reza Mohammadi,et al. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial , 2003, Journal of neurology, neurosurgery, and psychiatry.
[26] A. Cuadrado,et al. Effect of the Alzheimer amyloid fragment Aβ(25–35) on Akt/PKB kinase and survival of PC12 cells , 2001, Journal of neurochemistry.
[27] I. Grundke‐Iqbal,et al. Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.
[28] H. Jung,et al. Protective effect of diallyl disulfide on oxidative stress-injured neuronally differentiated PC12 cells. , 2005, Brain research. Molecular brain research.
[29] J. Ávila,et al. Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration , 1999 .
[30] D. Butterfield,et al. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.
[31] G. T. Liu,et al. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. , 1992, Biochemical pharmacology.
[32] Jeffrey A. Johnson,et al. Genetic Programming by the Proteolytic Fragments of the Amyloid Precursor Protein: Somewhere Between Confusion and Clarity , 2003, Reviews in the neurosciences.
[33] E. Perry,et al. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial , 2003, Pharmacology Biochemistry and Behavior.
[34] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[35] E. Perry,et al. Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy ** , 1999, The Journal of pharmacy and pharmacology.
[36] P. Doraiswamy. Non-cholinergic strategies for treating and preventing Alzheimer's disease. , 2002, CNS drugs.
[37] N. Holbrook,et al. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. , 1998, The Biochemical journal.
[38] N. Thornberry,et al. Caspases: killer proteases. , 1997, Trends in biochemical sciences.
[39] J. Hohmann,et al. Protective Effects of the Aerial Parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their Constituents against Enzyme-Dependent and Enzyme-Independent Lipid Peroxidation , 1999, Planta medica.
[40] D. Baričevič,et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. , 2001, Journal of ethnopharmacology.
[41] P. Adlard,et al. The cause of neuronal degeneration in Alzheimer's disease , 2000, Progress in Neurobiology.
[42] V. Šimánek,et al. Chemoprotective effect of plant phenolics against anthracycline‐induced toxicity on rat cardiomyocytes Part II. caffeic, chlorogenic and rosmarinic acids , 2004, Phytotherapy research : PTR.
[43] M. Citron. Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge. , 2004, Trends in pharmacological sciences.
[44] T. Kubo,et al. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. , 2002, Journal of neuroscience research.